Spero Therapeutics Inc (SPRO)

08:29 AM

Forecasting Spero Therapeutics Inc. price range with options dataWeekly Trend Report & Entry Point Strategy Guides - newser.com

08:29 AM

01:20 AM

Is Spero Therapeutics Inc a good long term investmentTechnology Stock Trends & Free Stock Index Interpretations - earlytimes.in

01:20 AM

Oct 12, 2025

Is Spero Therapeutics Inc. (2HA) stock positioned for digital growth eraMarket Risk Analysis & Weekly High Potential Stock Alerts - newser.com

Oct 12, 2025

Oct 10, 2025

Key resistance and support levels for Spero Therapeutics Inc.Portfolio Gains Report & Stock Timing and Entry Methods - newser.com

Oct 10, 2025

Oct 10, 2025

Sector ETF performance correlation with Spero Therapeutics Inc.July 2025 Reactions & Consistent Income Trade Recommendations - newser.com

Oct 10, 2025

Oct 10, 2025

Best Momentum Stock to Buy for October 10th - sharewise.com

Oct 10, 2025

Oct 09, 2025

Spero Therapeutics' (SPRO) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

What analysts say about Spero Therapeutics Inc stockSell Signals and Alerts & Breakthrough Investment Results - earlytimes.in

Oct 08, 2025

Oct 08, 2025

Spero Therapeutics (NASDAQ:SPRO) Rating Increased to Strong-Buy at Zacks Research - MarketBeat

Oct 08, 2025

Oct 06, 2025

October 2025's Promising Penny Stocks To Consider - simplywall.st

Oct 06, 2025

Oct 06, 2025

Key metrics from Spero Therapeutics Inc.’s quarterly dataWall Street Watch & Low Risk High Reward Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

How strong is Spero Therapeutics Inc. stock revenue growth2025 Biggest Moves & AI Driven Stock Reports - newser.com

Oct 06, 2025

Oct 05, 2025

Heatmap analysis for Spero Therapeutics Inc. and competitors2025 Institutional Moves & Weekly Breakout Watchlists - newser.com

Oct 05, 2025

Oct 05, 2025

Is Spero Therapeutics Inc. (2HA) stock safe for risk averse investors2025 Short Interest & Risk Adjusted Swing Trade Ideas - newser.com

Oct 05, 2025

Oct 03, 2025

Spero Therapeutics, Inc. (NASDAQ:SPRO) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Oct 03, 2025

Oct 03, 2025

Will Spero Therapeutics Inc. see short term momentumTrade Analysis Report & Daily Volume Surge Signals - newser.com

Oct 03, 2025

Sep 30, 2025

Spero Therapeutics CEO sells shares worth $121,159 - MSN

Sep 30, 2025

Sep 29, 2025

Spero Therapeutics Inc. stock trend forecastJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com

Sep 29, 2025